S-HFD is associated with gut dysbiosis and steatohepatitis-like features, highlighting the importance of fat sources in shaping microbiome-host interactions in metabolic disease.
Abstract
High-fat diets (HFDs) are known to disrupt gut microbiota, contributing to obesity, inflammation, and metabolic disorders. Although sucrose is a known driver of gut dysbiosis, the microbiome alterations caused by sucrose-free fish oil and sunflower oil-based HFDs remain unclear. To investigate how sucrose-free sunflower oil-based (S-HFD) and fish oil-based (F-HFD) high-fat diets influence gut microbiota composition, metabolic health, and liver inflammation in mice. C57BL/6 mice were fed either S-HFD or F-HFD for 24 weeks. Body weight, insulin sensitivity, liver inflammation, and gene expression were assessed. Gut microbiota composition was analyzed using 16S rRNA sequencing, followed by diversity analysis and taxonomic profiling with Microbiome Analyst and MIAOME tools. Despite similar body weights between groups, the gut microbiota composition differed significantly. The S-HFD group showed a higher abundance of Firmicutes (40%) compared to the F-HFD group (3%), while Verrucomicrobia were dominant in F-HFD (26%) and nearly absent in S-HFD. Taxa such as RF39, Christensenellaceae, Mogibacteriaceae, and Yaniella were enriched in S-HFD mice and associated with metabolic and immune dysregulation. S-HFD mice also had elevated fasting glucose, increased hepatic monocyte/macrophage (F4/80+) infiltration, macrovesicular steatosis, lobular inflammation, and upregulation of genes related to fatty acid oxidation (Cpt1a), monocyte chemotaxis (Ccl2), lipogenesis (Scd1, Fasn, Acaca), and glycolysis (Pklr). Conversely, F-HFD mice showed increased expression of the insulin-sensitive gene FATP1. Sucrose-free sunflower oil- and fish oil-based high-fat diets induce distinct gut microbiota changes and metabolic responses. S-HFD is associated with gut dysbiosis and steatohepatitis-like features, highlighting the importance of fat sources in shaping microbiome-host interactions in metabolic disease.
BACKGROUND
Obesity is a major global public health challenge. A high-fat diet (HFD) is a key contributing factor, closely associated with gut microbiota dysbiosis. Although immunomodulatory effects of Ganoderma lucidum spore oil (GLSO) have been reported, its role in lipid metabolism disorders and its interaction with...
Jia-Ning Zhang, Yuan-Lan Yang, Xin-Yi Zhou et al.· The Journal of the Science o...· 0 citations
Preliminary preclinical evidence supports further investigation of ZBO in the context of dietary strategies for alleviating HFD-induced obesity, and suggests that ZBO administration is associated with remodeling of the gut microbiota and correlated changes in fatty acid metabolic pathways.
Luchuanyang Sun, Shi-Qi Zhang, Hong-Juan Hu et al.· Nutrients· 0 citations
BACKGROUND
Gut dysbiosis, disrupted intestinal barrier integrity, and elevated bacterial lipopolysaccharide levels are hallmarks of obesity-related metabolic dysfunctions. Fish oil (FO) and tart cherry (TC) have individually been shown to modulate gut microbiota dysbiosis and improve gut integrity.
OBJECTIVE
We hypot...
Maryam Seifishahpar, Jung Han Kim, Mostafa Abdelrahman et al.· Journal of NutriLife· 0 citations
All interventions attenuated key features of HFD-induced metabolic dysfunction, particularly adiposity and lipid dysregulation, whereas improvements in glucose homeostasis remained limited, indicating mitigation of the metabolic phenotype.
Elisabetta De Rose, P. D'Aquila, V. Di Nardo et al.· Journal of Translational Med...· 0 citations
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver condition, influenced by factors such as obesity, insulin resistance, and hyperlipidemia. While ancient grains like highland barley (HB) and common buckwheat (BW) have shown potential to mitigate these factors, direct comparisons of their...
Tong Wu, Li Zhi, Lu-Man Sang et al.· Food Science and Human Welln...· 0 citations
Obesity is a major global health concern associated with various metabolic disorders. Fucoidan, a seaweed-derived sulfated polysaccharide, has shown potential in alleviating obesity through modulation of gut microbiota. However, comparative effects of native and depolymerized fucoidan (Dfuc) on HFD-induced obesity and...
Xiao-Na Sun, Lin Bai, Chang-Yu Su et al.· Foods· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.